nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Tamoxifen—SULT1A1—coronary artery disease	0.00181	0.14	CrCbGaD
Doxylamine—Doxepin—HRH2—coronary artery disease	0.00119	0.0917	CrCbGaD
Doxylamine—Dextropropoxyphene—OPRD1—coronary artery disease	0.000921	0.071	CrCbGaD
Doxylamine—Amitriptyline—HRH2—coronary artery disease	0.00092	0.0709	CrCbGaD
Doxylamine—Toremifene—ESR1—coronary artery disease	0.000786	0.0606	CrCbGaD
Doxylamine—Methadone—OPRD1—coronary artery disease	0.000625	0.0482	CrCbGaD
Doxylamine—Tamoxifen—ESR2—coronary artery disease	0.000509	0.0393	CrCbGaD
Doxylamine—Imipramine—SLC22A3—coronary artery disease	0.000496	0.0382	CrCbGaD
Doxylamine—Amitriptyline—OPRD1—coronary artery disease	0.000486	0.0374	CrCbGaD
Doxylamine—Carbinoxamine—CYP2C19—coronary artery disease	0.000448	0.0345	CrCbGaD
Doxylamine—Cyclobenzaprine—HTR2A—coronary artery disease	0.000442	0.034	CrCbGaD
Doxylamine—Hypotension—Losartan—coronary artery disease	0.00041	0.000544	CcSEcCtD
Doxylamine—Dizziness—Clopidogrel—coronary artery disease	0.000409	0.000543	CcSEcCtD
Doxylamine—Feeling abnormal—Telmisartan—coronary artery disease	0.000409	0.000542	CcSEcCtD
Doxylamine—Palpitations—Ramipril—coronary artery disease	0.000408	0.000541	CcSEcCtD
Doxylamine—Decreased appetite—Perindopril—coronary artery disease	0.000407	0.00054	CcSEcCtD
Doxylamine—Pruritus—Simvastatin—coronary artery disease	0.000407	0.00054	CcSEcCtD
Doxylamine—Dizziness—Lovastatin—coronary artery disease	0.000406	0.000539	CcSEcCtD
Doxylamine—Vertigo—Timolol—coronary artery disease	0.000405	0.000538	CcSEcCtD
Doxylamine—Somnolence—Furosemide—coronary artery disease	0.000405	0.000537	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000404	0.000536	CcSEcCtD
Doxylamine—Diarrhoea—Eplerenone—coronary artery disease	0.000404	0.000536	CcSEcCtD
Doxylamine—Fatigue—Perindopril—coronary artery disease	0.000404	0.000535	CcSEcCtD
Doxylamine—Muscle spasms—Lisinopril—coronary artery disease	0.000402	0.000534	CcSEcCtD
Doxylamine—Urticaria—Trandolapril—coronary artery disease	0.000401	0.000532	CcSEcCtD
Doxylamine—Constipation—Perindopril—coronary artery disease	0.0004	0.000531	CcSEcCtD
Doxylamine—Vomiting—Fenofibrate—coronary artery disease	0.0004	0.000531	CcSEcCtD
Doxylamine—Hypersensitivity—Valsartan—coronary artery disease	0.0004	0.000531	CcSEcCtD
Doxylamine—Convulsion—Ramipril—coronary artery disease	0.0004	0.00053	CcSEcCtD
Doxylamine—Urticaria—Enalapril—coronary artery disease	0.000399	0.00053	CcSEcCtD
Doxylamine—Dizziness—Ezetimibe—coronary artery disease	0.000399	0.000529	CcSEcCtD
Doxylamine—Palpitations—Timolol—coronary artery disease	0.000399	0.000529	CcSEcCtD
Doxylamine—Feeling abnormal—Captopril—coronary artery disease	0.000397	0.000527	CcSEcCtD
Doxylamine—Insomnia—Losartan—coronary artery disease	0.000397	0.000527	CcSEcCtD
Doxylamine—Rash—Fenofibrate—coronary artery disease	0.000397	0.000526	CcSEcCtD
Doxylamine—Dermatitis—Fenofibrate—coronary artery disease	0.000397	0.000526	CcSEcCtD
Doxylamine—Decreased appetite—Furosemide—coronary artery disease	0.000396	0.000525	CcSEcCtD
Doxylamine—Urticaria—Telmisartan—coronary artery disease	0.000394	0.000523	CcSEcCtD
Doxylamine—Vomiting—Clopidogrel—coronary artery disease	0.000393	0.000522	CcSEcCtD
Doxylamine—Diarrhoea—Simvastatin—coronary artery disease	0.000393	0.000522	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000393	0.000521	CcSEcCtD
Doxylamine—Fatigue—Furosemide—coronary artery disease	0.000392	0.00052	CcSEcCtD
Doxylamine—Tremor—Lisinopril—coronary artery disease	0.000392	0.00052	CcSEcCtD
Doxylamine—Dyspnoea—Losartan—coronary artery disease	0.000391	0.000519	CcSEcCtD
Doxylamine—Anxiety—Ramipril—coronary artery disease	0.000391	0.000519	CcSEcCtD
Doxylamine—Vomiting—Lovastatin—coronary artery disease	0.000391	0.000518	CcSEcCtD
Doxylamine—Somnolence—Losartan—coronary artery disease	0.00039	0.000518	CcSEcCtD
Doxylamine—Dizziness—Eplerenone—coronary artery disease	0.00039	0.000518	CcSEcCtD
Doxylamine—Rash—Clopidogrel—coronary artery disease	0.00039	0.000518	CcSEcCtD
Doxylamine—Dermatitis—Clopidogrel—coronary artery disease	0.00039	0.000517	CcSEcCtD
Doxylamine—Asthenia—Valsartan—coronary artery disease	0.00039	0.000517	CcSEcCtD
Doxylamine—Constipation—Furosemide—coronary artery disease	0.000389	0.000516	CcSEcCtD
Doxylamine—Hypersensitivity—Niacin—coronary artery disease	0.000389	0.000516	CcSEcCtD
Doxylamine—Brompheniramine—CYP2C19—coronary artery disease	0.000388	0.0299	CrCbGaD
Doxylamine—Ill-defined disorder—Lisinopril—coronary artery disease	0.000388	0.000515	CcSEcCtD
Doxylamine—Discomfort—Ramipril—coronary artery disease	0.000388	0.000515	CcSEcCtD
Doxylamine—Asthenia—Olmesartan—coronary artery disease	0.000388	0.000514	CcSEcCtD
Doxylamine—Rash—Lovastatin—coronary artery disease	0.000388	0.000514	CcSEcCtD
Doxylamine—Dermatitis—Lovastatin—coronary artery disease	0.000387	0.000514	CcSEcCtD
Doxylamine—Feeling abnormal—Perindopril—coronary artery disease	0.000386	0.000512	CcSEcCtD
Doxylamine—Pruritus—Valsartan—coronary artery disease	0.000384	0.00051	CcSEcCtD
Doxylamine—Dry mouth—Ramipril—coronary artery disease	0.000384	0.00051	CcSEcCtD
Doxylamine—Vomiting—Ezetimibe—coronary artery disease	0.000383	0.000508	CcSEcCtD
Doxylamine—Hypersensitivity—Pravastatin—coronary artery disease	0.000383	0.000508	CcSEcCtD
Doxylamine—Anxiety—Timolol—coronary artery disease	0.000383	0.000508	CcSEcCtD
Doxylamine—Angioedema—Lisinopril—coronary artery disease	0.000382	0.000507	CcSEcCtD
Doxylamine—Pruritus—Olmesartan—coronary artery disease	0.000382	0.000507	CcSEcCtD
Doxylamine—Decreased appetite—Losartan—coronary artery disease	0.000382	0.000506	CcSEcCtD
Doxylamine—Dizziness—Simvastatin—coronary artery disease	0.00038	0.000504	CcSEcCtD
Doxylamine—Rash—Ezetimibe—coronary artery disease	0.00038	0.000504	CcSEcCtD
Doxylamine—Dermatitis—Ezetimibe—coronary artery disease	0.00038	0.000504	CcSEcCtD
Doxylamine—Confusional state—Ramipril—coronary artery disease	0.00038	0.000504	CcSEcCtD
Doxylamine—Discomfort—Timolol—coronary artery disease	0.000379	0.000503	CcSEcCtD
Doxylamine—Asthenia—Niacin—coronary artery disease	0.000379	0.000502	CcSEcCtD
Doxylamine—Fatigue—Losartan—coronary artery disease	0.000379	0.000502	CcSEcCtD
Doxylamine—Malaise—Lisinopril—coronary artery disease	0.000377	0.0005	CcSEcCtD
Doxylamine—Anaphylactic shock—Ramipril—coronary artery disease	0.000377	0.000499	CcSEcCtD
Doxylamine—Vertigo—Lisinopril—coronary artery disease	0.000376	0.000499	CcSEcCtD
Doxylamine—Dry mouth—Timolol—coronary artery disease	0.000376	0.000498	CcSEcCtD
Doxylamine—Constipation—Losartan—coronary artery disease	0.000376	0.000498	CcSEcCtD
Doxylamine—Vomiting—Eplerenone—coronary artery disease	0.000375	0.000498	CcSEcCtD
Doxylamine—Feeling abnormal—Furosemide—coronary artery disease	0.000375	0.000497	CcSEcCtD
Doxylamine—Leukopenia—Lisinopril—coronary artery disease	0.000375	0.000497	CcSEcCtD
Doxylamine—Nausea—Fenofibrate—coronary artery disease	0.000374	0.000496	CcSEcCtD
Doxylamine—Pruritus—Niacin—coronary artery disease	0.000373	0.000495	CcSEcCtD
Doxylamine—Asthenia—Pravastatin—coronary artery disease	0.000373	0.000495	CcSEcCtD
Doxylamine—Rash—Eplerenone—coronary artery disease	0.000372	0.000494	CcSEcCtD
Doxylamine—Urticaria—Perindopril—coronary artery disease	0.000372	0.000493	CcSEcCtD
Doxylamine—Hypersensitivity—Trandolapril—coronary artery disease	0.000372	0.000493	CcSEcCtD
Doxylamine—Dermatitis—Eplerenone—coronary artery disease	0.000372	0.000493	CcSEcCtD
Doxylamine—Diarrhoea—Valsartan—coronary artery disease	0.000371	0.000493	CcSEcCtD
Doxylamine—Confusional state—Timolol—coronary artery disease	0.000371	0.000492	CcSEcCtD
Doxylamine—Hypersensitivity—Enalapril—coronary artery disease	0.00037	0.000491	CcSEcCtD
Doxylamine—Palpitations—Lisinopril—coronary artery disease	0.00037	0.00049	CcSEcCtD
Doxylamine—Diarrhoea—Olmesartan—coronary artery disease	0.00037	0.00049	CcSEcCtD
Doxylamine—Nervous system disorder—Ramipril—coronary artery disease	0.000369	0.00049	CcSEcCtD
Doxylamine—Thrombocytopenia—Ramipril—coronary artery disease	0.000369	0.000489	CcSEcCtD
Doxylamine—Anaphylactic shock—Timolol—coronary artery disease	0.000368	0.000488	CcSEcCtD
Doxylamine—Pruritus—Pravastatin—coronary artery disease	0.000368	0.000488	CcSEcCtD
Doxylamine—Nausea—Clopidogrel—coronary artery disease	0.000368	0.000488	CcSEcCtD
Doxylamine—Tachycardia—Ramipril—coronary artery disease	0.000367	0.000487	CcSEcCtD
Doxylamine—Vomiting—Simvastatin—coronary artery disease	0.000366	0.000485	CcSEcCtD
Doxylamine—Hypersensitivity—Telmisartan—coronary artery disease	0.000365	0.000485	CcSEcCtD
Doxylamine—Nausea—Lovastatin—coronary artery disease	0.000365	0.000484	CcSEcCtD
Doxylamine—Hyperhidrosis—Ramipril—coronary artery disease	0.000364	0.000483	CcSEcCtD
Doxylamine—Rash—Simvastatin—coronary artery disease	0.000363	0.000481	CcSEcCtD
Doxylamine—Dermatitis—Simvastatin—coronary artery disease	0.000362	0.00048	CcSEcCtD
Doxylamine—Asthenia—Trandolapril—coronary artery disease	0.000362	0.00048	CcSEcCtD
Doxylamine—Feeling abnormal—Losartan—coronary artery disease	0.000362	0.00048	CcSEcCtD
Doxylamine—Urticaria—Furosemide—coronary artery disease	0.000362	0.00048	CcSEcCtD
Doxylamine—Diarrhoea—Niacin—coronary artery disease	0.000361	0.000479	CcSEcCtD
Doxylamine—Nervous system disorder—Timolol—coronary artery disease	0.000361	0.000479	CcSEcCtD
Doxylamine—Asthenia—Enalapril—coronary artery disease	0.000361	0.000478	CcSEcCtD
Doxylamine—Dizziness—Valsartan—coronary artery disease	0.000359	0.000476	CcSEcCtD
Doxylamine—Anorexia—Ramipril—coronary artery disease	0.000359	0.000476	CcSEcCtD
Doxylamine—Nausea—Ezetimibe—coronary artery disease	0.000358	0.000475	CcSEcCtD
Doxylamine—Dizziness—Olmesartan—coronary artery disease	0.000357	0.000474	CcSEcCtD
Doxylamine—Pruritus—Trandolapril—coronary artery disease	0.000357	0.000474	CcSEcCtD
Doxylamine—Hyperhidrosis—Timolol—coronary artery disease	0.000356	0.000472	CcSEcCtD
Doxylamine—Asthenia—Telmisartan—coronary artery disease	0.000356	0.000472	CcSEcCtD
Doxylamine—Pruritus—Enalapril—coronary artery disease	0.000356	0.000472	CcSEcCtD
Doxylamine—Diarrhoea—Pravastatin—coronary artery disease	0.000356	0.000472	CcSEcCtD
Doxylamine—Anxiety—Lisinopril—coronary artery disease	0.000355	0.000471	CcSEcCtD
Doxylamine—Discomfort—Lisinopril—coronary artery disease	0.000352	0.000467	CcSEcCtD
Doxylamine—Hypotension—Ramipril—coronary artery disease	0.000352	0.000467	CcSEcCtD
Doxylamine—Anorexia—Timolol—coronary artery disease	0.000351	0.000465	CcSEcCtD
Doxylamine—Pruritus—Telmisartan—coronary artery disease	0.000351	0.000465	CcSEcCtD
Doxylamine—Nausea—Eplerenone—coronary artery disease	0.00035	0.000465	CcSEcCtD
Doxylamine—Dizziness—Niacin—coronary artery disease	0.000349	0.000463	CcSEcCtD
Doxylamine—Urticaria—Losartan—coronary artery disease	0.000349	0.000463	CcSEcCtD
Doxylamine—Dry mouth—Lisinopril—coronary artery disease	0.000348	0.000462	CcSEcCtD
Doxylamine—Asthenia—Captopril—coronary artery disease	0.000346	0.000459	CcSEcCtD
Doxylamine—Diarrhoea—Trandolapril—coronary artery disease	0.000345	0.000458	CcSEcCtD
Doxylamine—Vomiting—Valsartan—coronary artery disease	0.000345	0.000458	CcSEcCtD
Doxylamine—Confusional state—Lisinopril—coronary artery disease	0.000344	0.000457	CcSEcCtD
Doxylamine—Diarrhoea—Enalapril—coronary artery disease	0.000344	0.000456	CcSEcCtD
Doxylamine—Hypotension—Timolol—coronary artery disease	0.000344	0.000456	CcSEcCtD
Doxylamine—Dizziness—Pravastatin—coronary artery disease	0.000344	0.000456	CcSEcCtD
Doxylamine—Vomiting—Olmesartan—coronary artery disease	0.000344	0.000456	CcSEcCtD
Doxylamine—Rash—Valsartan—coronary artery disease	0.000342	0.000454	CcSEcCtD
Doxylamine—Dermatitis—Valsartan—coronary artery disease	0.000342	0.000454	CcSEcCtD
Doxylamine—Nausea—Simvastatin—coronary artery disease	0.000342	0.000453	CcSEcCtD
Doxylamine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000341	0.000453	CcSEcCtD
Doxylamine—Pruritus—Captopril—coronary artery disease	0.000341	0.000453	CcSEcCtD
Doxylamine—Rash—Olmesartan—coronary artery disease	0.000341	0.000452	CcSEcCtD
Doxylamine—Insomnia—Ramipril—coronary artery disease	0.000341	0.000452	CcSEcCtD
Doxylamine—Dermatitis—Olmesartan—coronary artery disease	0.00034	0.000452	CcSEcCtD
Doxylamine—Diarrhoea—Telmisartan—coronary artery disease	0.000339	0.00045	CcSEcCtD
Doxylamine—Asthenia—Perindopril—coronary artery disease	0.000336	0.000446	CcSEcCtD
Doxylamine—Dyspnoea—Ramipril—coronary artery disease	0.000336	0.000445	CcSEcCtD
Doxylamine—Vomiting—Niacin—coronary artery disease	0.000336	0.000445	CcSEcCtD
Doxylamine—Hypersensitivity—Furosemide—coronary artery disease	0.000335	0.000445	CcSEcCtD
Doxylamine—Somnolence—Ramipril—coronary artery disease	0.000335	0.000444	CcSEcCtD
Doxylamine—Thrombocytopenia—Lisinopril—coronary artery disease	0.000334	0.000443	CcSEcCtD
Doxylamine—Dizziness—Trandolapril—coronary artery disease	0.000334	0.000443	CcSEcCtD
Doxylamine—Tachycardia—Lisinopril—coronary artery disease	0.000333	0.000442	CcSEcCtD
Doxylamine—Insomnia—Timolol—coronary artery disease	0.000333	0.000442	CcSEcCtD
Doxylamine—Rash—Niacin—coronary artery disease	0.000333	0.000442	CcSEcCtD
Doxylamine—Dermatitis—Niacin—coronary artery disease	0.000333	0.000441	CcSEcCtD
Doxylamine—Dizziness—Enalapril—coronary artery disease	0.000332	0.000441	CcSEcCtD
Doxylamine—Pruritus—Perindopril—coronary artery disease	0.000331	0.000439	CcSEcCtD
Doxylamine—Vomiting—Pravastatin—coronary artery disease	0.00033	0.000438	CcSEcCtD
Doxylamine—Hyperhidrosis—Lisinopril—coronary artery disease	0.00033	0.000438	CcSEcCtD
Doxylamine—Diarrhoea—Captopril—coronary artery disease	0.00033	0.000438	CcSEcCtD
Doxylamine—Dyspnoea—Timolol—coronary artery disease	0.000328	0.000435	CcSEcCtD
Doxylamine—Dizziness—Telmisartan—coronary artery disease	0.000328	0.000435	CcSEcCtD
Doxylamine—Rash—Pravastatin—coronary artery disease	0.000328	0.000435	CcSEcCtD
Doxylamine—Dermatitis—Pravastatin—coronary artery disease	0.000327	0.000434	CcSEcCtD
Doxylamine—Decreased appetite—Ramipril—coronary artery disease	0.000327	0.000434	CcSEcCtD
Doxylamine—Somnolence—Timolol—coronary artery disease	0.000327	0.000434	CcSEcCtD
Doxylamine—Asthenia—Furosemide—coronary artery disease	0.000327	0.000433	CcSEcCtD
Doxylamine—Anorexia—Lisinopril—coronary artery disease	0.000325	0.000432	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000325	0.000431	CcSEcCtD
Doxylamine—Fatigue—Ramipril—coronary artery disease	0.000325	0.000431	CcSEcCtD
Doxylamine—Hypersensitivity—Losartan—coronary artery disease	0.000324	0.000429	CcSEcCtD
Doxylamine—Nausea—Valsartan—coronary artery disease	0.000323	0.000428	CcSEcCtD
Doxylamine—Pruritus—Furosemide—coronary artery disease	0.000322	0.000427	CcSEcCtD
Doxylamine—Constipation—Ramipril—coronary artery disease	0.000322	0.000427	CcSEcCtD
Doxylamine—Nausea—Olmesartan—coronary artery disease	0.000321	0.000426	CcSEcCtD
Doxylamine—Vomiting—Trandolapril—coronary artery disease	0.000321	0.000426	CcSEcCtD
Doxylamine—Diarrhoea—Perindopril—coronary artery disease	0.00032	0.000425	CcSEcCtD
Doxylamine—Atomoxetine—CYP2C19—coronary artery disease	0.00032	0.0247	CrCbGaD
Doxylamine—Decreased appetite—Timolol—coronary artery disease	0.00032	0.000424	CcSEcCtD
Doxylamine—Vomiting—Enalapril—coronary artery disease	0.00032	0.000424	CcSEcCtD
Doxylamine—Hypotension—Lisinopril—coronary artery disease	0.000319	0.000423	CcSEcCtD
Doxylamine—Dizziness—Captopril—coronary artery disease	0.000319	0.000423	CcSEcCtD
Doxylamine—Rash—Trandolapril—coronary artery disease	0.000318	0.000422	CcSEcCtD
Doxylamine—Dermatitis—Trandolapril—coronary artery disease	0.000318	0.000422	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000318	0.000422	CcSEcCtD
Doxylamine—Fatigue—Timolol—coronary artery disease	0.000317	0.000421	CcSEcCtD
Doxylamine—Rash—Enalapril—coronary artery disease	0.000317	0.00042	CcSEcCtD
Doxylamine—Dermatitis—Enalapril—coronary artery disease	0.000317	0.00042	CcSEcCtD
Doxylamine—Vomiting—Telmisartan—coronary artery disease	0.000315	0.000418	CcSEcCtD
Doxylamine—Asthenia—Losartan—coronary artery disease	0.000315	0.000418	CcSEcCtD
Doxylamine—Imipramine—HTR7—coronary artery disease	0.000315	0.0243	CrCbGaD
Doxylamine—Tamoxifen—ESR1—coronary artery disease	0.000314	0.0242	CrCbGaD
Doxylamine—Nausea—Niacin—coronary artery disease	0.000314	0.000416	CcSEcCtD
Doxylamine—Amitriptyline—HTR7—coronary artery disease	0.000313	0.0241	CrCbGaD
Doxylamine—Rash—Telmisartan—coronary artery disease	0.000313	0.000415	CcSEcCtD
Doxylamine—Dermatitis—Telmisartan—coronary artery disease	0.000312	0.000414	CcSEcCtD
Doxylamine—Diarrhoea—Furosemide—coronary artery disease	0.000311	0.000413	CcSEcCtD
Doxylamine—Pruritus—Losartan—coronary artery disease	0.000311	0.000412	CcSEcCtD
Doxylamine—Feeling abnormal—Ramipril—coronary artery disease	0.00031	0.000412	CcSEcCtD
Doxylamine—Dizziness—Perindopril—coronary artery disease	0.00031	0.000411	CcSEcCtD
Doxylamine—Insomnia—Lisinopril—coronary artery disease	0.000309	0.00041	CcSEcCtD
Doxylamine—Nausea—Pravastatin—coronary artery disease	0.000309	0.00041	CcSEcCtD
Doxylamine—Vomiting—Captopril—coronary artery disease	0.000307	0.000407	CcSEcCtD
Doxylamine—Dyspnoea—Lisinopril—coronary artery disease	0.000304	0.000404	CcSEcCtD
Doxylamine—Rash—Captopril—coronary artery disease	0.000304	0.000403	CcSEcCtD
Doxylamine—Dermatitis—Captopril—coronary artery disease	0.000304	0.000403	CcSEcCtD
Doxylamine—Somnolence—Lisinopril—coronary artery disease	0.000304	0.000403	CcSEcCtD
Doxylamine—Feeling abnormal—Timolol—coronary artery disease	0.000303	0.000402	CcSEcCtD
Doxylamine—Dizziness—Furosemide—coronary artery disease	0.000301	0.000399	CcSEcCtD
Doxylamine—Diarrhoea—Losartan—coronary artery disease	0.0003	0.000399	CcSEcCtD
Doxylamine—Nausea—Trandolapril—coronary artery disease	0.0003	0.000398	CcSEcCtD
Doxylamine—Urticaria—Ramipril—coronary artery disease	0.000299	0.000397	CcSEcCtD
Doxylamine—Nausea—Enalapril—coronary artery disease	0.000299	0.000396	CcSEcCtD
Doxylamine—Vomiting—Perindopril—coronary artery disease	0.000298	0.000395	CcSEcCtD
Doxylamine—Decreased appetite—Lisinopril—coronary artery disease	0.000297	0.000394	CcSEcCtD
Doxylamine—Rash—Perindopril—coronary artery disease	0.000295	0.000392	CcSEcCtD
Doxylamine—Dermatitis—Perindopril—coronary artery disease	0.000295	0.000391	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000295	0.000391	CcSEcCtD
Doxylamine—Nausea—Telmisartan—coronary artery disease	0.000295	0.000391	CcSEcCtD
Doxylamine—Fatigue—Lisinopril—coronary artery disease	0.000294	0.000391	CcSEcCtD
Doxylamine—Urticaria—Timolol—coronary artery disease	0.000292	0.000388	CcSEcCtD
Doxylamine—Constipation—Lisinopril—coronary artery disease	0.000292	0.000387	CcSEcCtD
Doxylamine—Dizziness—Losartan—coronary artery disease	0.00029	0.000385	CcSEcCtD
Doxylamine—Vomiting—Furosemide—coronary artery disease	0.000289	0.000384	CcSEcCtD
Doxylamine—Rash—Furosemide—coronary artery disease	0.000287	0.000381	CcSEcCtD
Doxylamine—Dermatitis—Furosemide—coronary artery disease	0.000287	0.00038	CcSEcCtD
Doxylamine—Nausea—Captopril—coronary artery disease	0.000286	0.00038	CcSEcCtD
Doxylamine—Feeling abnormal—Lisinopril—coronary artery disease	0.000281	0.000373	CcSEcCtD
Doxylamine—Vomiting—Losartan—coronary artery disease	0.000279	0.00037	CcSEcCtD
Doxylamine—Nausea—Perindopril—coronary artery disease	0.000278	0.000369	CcSEcCtD
Doxylamine—Hypersensitivity—Ramipril—coronary artery disease	0.000277	0.000368	CcSEcCtD
Doxylamine—Rash—Losartan—coronary artery disease	0.000277	0.000367	CcSEcCtD
Doxylamine—Dermatitis—Losartan—coronary artery disease	0.000277	0.000367	CcSEcCtD
Doxylamine—Urticaria—Lisinopril—coronary artery disease	0.000271	0.00036	CcSEcCtD
Doxylamine—Hypersensitivity—Timolol—coronary artery disease	0.000271	0.00036	CcSEcCtD
Doxylamine—Nausea—Furosemide—coronary artery disease	0.00027	0.000359	CcSEcCtD
Doxylamine—Asthenia—Ramipril—coronary artery disease	0.00027	0.000358	CcSEcCtD
Doxylamine—Pruritus—Ramipril—coronary artery disease	0.000266	0.000353	CcSEcCtD
Doxylamine—Asthenia—Timolol—coronary artery disease	0.000264	0.00035	CcSEcCtD
Doxylamine—Nausea—Losartan—coronary artery disease	0.000261	0.000346	CcSEcCtD
Doxylamine—Pruritus—Timolol—coronary artery disease	0.00026	0.000345	CcSEcCtD
Doxylamine—Atomoxetine—HTR2A—coronary artery disease	0.00026	0.02	CrCbGaD
Doxylamine—Diphenhydramine—CYP2C19—coronary artery disease	0.000259	0.0199	CrCbGaD
Doxylamine—Diarrhoea—Ramipril—coronary artery disease	0.000258	0.000342	CcSEcCtD
Doxylamine—Diarrhoea—Timolol—coronary artery disease	0.000252	0.000334	CcSEcCtD
Doxylamine—Tamoxifen—CYP2C19—coronary artery disease	0.000252	0.0194	CrCbGaD
Doxylamine—Hypersensitivity—Lisinopril—coronary artery disease	0.000252	0.000334	CcSEcCtD
Doxylamine—Doxepin—CYP2C19—coronary artery disease	0.000251	0.0193	CrCbGaD
Doxylamine—Methadone—CYP2C19—coronary artery disease	0.00025	0.0192	CrCbGaD
Doxylamine—Dizziness—Ramipril—coronary artery disease	0.000249	0.00033	CcSEcCtD
Doxylamine—Asthenia—Lisinopril—coronary artery disease	0.000245	0.000325	CcSEcCtD
Doxylamine—Dizziness—Timolol—coronary artery disease	0.000243	0.000323	CcSEcCtD
Doxylamine—Pruritus—Lisinopril—coronary artery disease	0.000242	0.00032	CcSEcCtD
Doxylamine—Vomiting—Ramipril—coronary artery disease	0.000239	0.000318	CcSEcCtD
Doxylamine—Rash—Ramipril—coronary artery disease	0.000237	0.000315	CcSEcCtD
Doxylamine—Dermatitis—Ramipril—coronary artery disease	0.000237	0.000315	CcSEcCtD
Doxylamine—Vomiting—Timolol—coronary artery disease	0.000234	0.00031	CcSEcCtD
Doxylamine—Diarrhoea—Lisinopril—coronary artery disease	0.000234	0.00031	CcSEcCtD
Doxylamine—Rash—Timolol—coronary artery disease	0.000232	0.000308	CcSEcCtD
Doxylamine—Dermatitis—Timolol—coronary artery disease	0.000232	0.000308	CcSEcCtD
Doxylamine—Dizziness—Lisinopril—coronary artery disease	0.000226	0.0003	CcSEcCtD
Doxylamine—Nausea—Ramipril—coronary artery disease	0.000224	0.000297	CcSEcCtD
Doxylamine—Promazine—CYP2C19—coronary artery disease	0.000223	0.0172	CrCbGaD
Doxylamine—Nausea—Timolol—coronary artery disease	0.000219	0.00029	CcSEcCtD
Doxylamine—Vomiting—Lisinopril—coronary artery disease	0.000217	0.000288	CcSEcCtD
Doxylamine—Rash—Lisinopril—coronary artery disease	0.000215	0.000286	CcSEcCtD
Doxylamine—Dermatitis—Lisinopril—coronary artery disease	0.000215	0.000285	CcSEcCtD
Doxylamine—Doxepin—HTR2A—coronary artery disease	0.000203	0.0157	CrCbGaD
Doxylamine—Nausea—Lisinopril—coronary artery disease	0.000203	0.000269	CcSEcCtD
Doxylamine—Imipramine—CYP2C19—coronary artery disease	0.000195	0.0151	CrCbGaD
Doxylamine—Amitriptyline—CYP2C19—coronary artery disease	0.000194	0.015	CrCbGaD
Doxylamine—Promazine—HTR2A—coronary artery disease	0.000181	0.0139	CrCbGaD
Doxylamine—Imipramine—HTR2A—coronary artery disease	0.000158	0.0122	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—coronary artery disease	0.000157	0.0121	CrCbGaD
Doxylamine—Amitriptyline—ALB—coronary artery disease	0.000108	0.0083	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—CCL5—coronary artery disease	6.79e-05	0.000291	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PPP3R1—coronary artery disease	6.78e-05	0.000291	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CCL5—coronary artery disease	6.77e-05	0.00029	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PPP3R1—coronary artery disease	6.76e-05	0.00029	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADM—coronary artery disease	6.72e-05	0.000288	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADM—coronary artery disease	6.7e-05	0.000287	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CSF2—coronary artery disease	6.69e-05	0.000287	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CSF2—coronary artery disease	6.66e-05	0.000286	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CYBB—coronary artery disease	6.55e-05	0.000281	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDE4B—coronary artery disease	6.55e-05	0.000281	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—CXCL8—coronary artery disease	6.54e-05	0.000281	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MMP3—coronary artery disease	6.53e-05	0.00028	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDE4B—coronary artery disease	6.52e-05	0.00028	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CYBB—coronary artery disease	6.52e-05	0.00028	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—CXCL8—coronary artery disease	6.52e-05	0.00028	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	6.52e-05	0.000279	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MMP3—coronary artery disease	6.51e-05	0.000279	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	6.5e-05	0.000279	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDN1—coronary artery disease	6.21e-05	0.000266	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDN1—coronary artery disease	6.19e-05	0.000266	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL5—coronary artery disease	6.16e-05	0.000264	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL5—coronary artery disease	6.14e-05	0.000263	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PRKCD—coronary artery disease	6.11e-05	0.000262	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PRKCD—coronary artery disease	6.1e-05	0.000261	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CSF2—coronary artery disease	6.07e-05	0.00026	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CSF2—coronary artery disease	6.05e-05	0.00026	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCR3—coronary artery disease	5.99e-05	0.000257	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—coronary artery disease	5.98e-05	0.000257	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—C3—coronary artery disease	5.98e-05	0.000256	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCR3—coronary artery disease	5.97e-05	0.000256	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—coronary artery disease	5.96e-05	0.000256	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—C3—coronary artery disease	5.96e-05	0.000255	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CRK—coronary artery disease	5.91e-05	0.000253	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CRK—coronary artery disease	5.89e-05	0.000253	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SH2B3—coronary artery disease	5.83e-05	0.00025	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VWF—coronary artery disease	5.83e-05	0.00025	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ATP2A2—coronary artery disease	5.83e-05	0.00025	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SH2B3—coronary artery disease	5.82e-05	0.000249	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ATP2A2—coronary artery disease	5.82e-05	0.000249	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VWF—coronary artery disease	5.82e-05	0.000249	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOC3—coronary artery disease	5.8e-05	0.000249	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOC3—coronary artery disease	5.78e-05	0.000248	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LDLR—coronary artery disease	5.76e-05	0.000247	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LDLR—coronary artery disease	5.74e-05	0.000246	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AGT—coronary artery disease	5.68e-05	0.000244	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AGT—coronary artery disease	5.66e-05	0.000243	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PPP2CA—coronary artery disease	5.65e-05	0.000243	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PPP2CA—coronary artery disease	5.64e-05	0.000242	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	5.63e-05	0.000241	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL3—coronary artery disease	5.63e-05	0.000241	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL2—coronary artery disease	5.61e-05	0.000241	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL3—coronary artery disease	5.61e-05	0.000241	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SDC1—coronary artery disease	5.57e-05	0.000239	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—F2R—coronary artery disease	5.57e-05	0.000239	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	5.55e-05	0.000238	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SDC1—coronary artery disease	5.55e-05	0.000238	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—F2R—coronary artery disease	5.55e-05	0.000238	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PRKCD—coronary artery disease	5.53e-05	0.000237	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGB—coronary artery disease	5.45e-05	0.000234	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	5.43e-05	0.000233	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGB—coronary artery disease	5.43e-05	0.000233	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—C3—coronary artery disease	5.43e-05	0.000233	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—coronary artery disease	5.42e-05	0.000232	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—C3—coronary artery disease	5.41e-05	0.000232	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	5.39e-05	0.000231	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRB—coronary artery disease	5.37e-05	0.00023	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—THBS1—coronary artery disease	5.31e-05	0.000228	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—THBS1—coronary artery disease	5.29e-05	0.000227	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	5.26e-05	0.000226	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	5.26e-05	0.000226	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—F2—coronary artery disease	5.25e-05	0.000225	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PSMB5—coronary artery disease	5.24e-05	0.000225	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PSMA6—coronary artery disease	5.24e-05	0.000225	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—F2—coronary artery disease	5.23e-05	0.000224	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AGT—coronary artery disease	5.16e-05	0.000221	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AGT—coronary artery disease	5.14e-05	0.00022	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	5.09e-05	0.000218	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDNRA—coronary artery disease	5.07e-05	0.000218	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CYBA—coronary artery disease	5.07e-05	0.000217	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	5.07e-05	0.000217	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CYBA—coronary artery disease	5.05e-05	0.000217	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB1—coronary artery disease	5.05e-05	0.000217	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	5.05e-05	0.000216	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DUSP6—coronary artery disease	5.03e-05	0.000216	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLAT—coronary artery disease	4.96e-05	0.000213	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLAT—coronary artery disease	4.94e-05	0.000212	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	4.79e-05	0.000205	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	4.79e-05	0.000205	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	4.78e-05	0.000205	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—BDKRB2—coronary artery disease	4.77e-05	0.000205	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL12—coronary artery disease	4.77e-05	0.000205	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—F2—coronary artery disease	4.76e-05	0.000204	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—POMC—coronary artery disease	4.76e-05	0.000204	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—F2—coronary artery disease	4.75e-05	0.000204	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	4.74e-05	0.000204	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6ST—coronary artery disease	4.73e-05	0.000203	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JUNB—coronary artery disease	4.7e-05	0.000201	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JUNB—coronary artery disease	4.68e-05	0.000201	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	4.68e-05	0.000201	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	4.67e-05	0.0002	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR7—coronary artery disease	4.58e-05	0.000197	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR7—coronary artery disease	4.57e-05	0.000196	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	4.37e-05	0.000187	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KNG1—coronary artery disease	4.35e-05	0.000187	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	4.35e-05	0.000187	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KNG1—coronary artery disease	4.34e-05	0.000186	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—POMC—coronary artery disease	4.34e-05	0.000186	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	4.34e-05	0.000186	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	4.33e-05	0.000186	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—POMC—coronary artery disease	4.33e-05	0.000186	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	4.33e-05	0.000186	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	4.31e-05	0.000185	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	4.25e-05	0.000182	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	4.23e-05	0.000182	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	4.23e-05	0.000182	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	4.23e-05	0.000181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	4.22e-05	0.000181	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PLG—coronary artery disease	4.22e-05	0.000181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	4.22e-05	0.000181	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PLG—coronary artery disease	4.2e-05	0.00018	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	4.11e-05	0.000176	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	4.09e-05	0.000176	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	4.05e-05	0.000174	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	4.05e-05	0.000174	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	4.04e-05	0.000173	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	4.04e-05	0.000173	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	4.04e-05	0.000173	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—S100B—coronary artery disease	4.03e-05	0.000173	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	4.03e-05	0.000173	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—S100B—coronary artery disease	4.02e-05	0.000172	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	3.99e-05	0.000171	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	3.98e-05	0.000171	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KITLG—coronary artery disease	3.95e-05	0.000169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	3.95e-05	0.000169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KITLG—coronary artery disease	3.93e-05	0.000169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	3.93e-05	0.000169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	3.86e-05	0.000165	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP3—coronary artery disease	3.86e-05	0.000165	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	3.85e-05	0.000165	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP3—coronary artery disease	3.85e-05	0.000165	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOB—coronary artery disease	3.73e-05	0.00016	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOB—coronary artery disease	3.72e-05	0.000159	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	3.7e-05	0.000159	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	3.68e-05	0.000158	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	3.68e-05	0.000158	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDN1—coronary artery disease	3.67e-05	0.000157	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	3.67e-05	0.000157	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDN1—coronary artery disease	3.66e-05	0.000157	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL5—coronary artery disease	3.64e-05	0.000156	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL5—coronary artery disease	3.63e-05	0.000156	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF1—coronary artery disease	3.59e-05	0.000154	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CSF2—coronary artery disease	3.59e-05	0.000154	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CSF2—coronary artery disease	3.57e-05	0.000153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF1—coronary artery disease	3.57e-05	0.000153	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LPL—coronary artery disease	3.56e-05	0.000153	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LPL—coronary artery disease	3.55e-05	0.000152	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	3.53e-05	0.000151	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	3.53e-05	0.000151	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	3.52e-05	0.000151	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	3.52e-05	0.000151	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	3.44e-05	0.000147	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	3.43e-05	0.000147	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.36e-05	0.000144	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	3.35e-05	0.000144	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.34e-05	0.000143	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	3.33e-05	0.000143	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3.28e-05	0.000141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	3.27e-05	0.00014	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	3.21e-05	0.000138	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—C3—coronary artery disease	3.21e-05	0.000137	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	3.2e-05	0.000137	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—C3—coronary artery disease	3.2e-05	0.000137	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	3.06e-05	0.000131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	3.05e-05	0.000131	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AGT—coronary artery disease	3.05e-05	0.000131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AGT—coronary artery disease	3.04e-05	0.00013	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOE—coronary artery disease	2.98e-05	0.000128	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—LEP—coronary artery disease	2.98e-05	0.000128	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—LEP—coronary artery disease	2.97e-05	0.000128	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOE—coronary artery disease	2.97e-05	0.000128	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOA1—coronary artery disease	2.95e-05	0.000127	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	2.94e-05	0.000126	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KDR—coronary artery disease	2.92e-05	0.000125	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KDR—coronary artery disease	2.91e-05	0.000125	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	2.9e-05	0.000125	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	2.9e-05	0.000124	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ESR1—coronary artery disease	2.85e-05	0.000122	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	2.84e-05	0.000122	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FN1—coronary artery disease	2.81e-05	0.000121	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—F2—coronary artery disease	2.81e-05	0.000121	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—F2—coronary artery disease	2.81e-05	0.00012	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FN1—coronary artery disease	2.81e-05	0.00012	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.8e-05	0.00012	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	2.79e-05	0.00012	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.78e-05	0.000119	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	2.77e-05	0.000119	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—KIT—coronary artery disease	2.69e-05	0.000116	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—KIT—coronary artery disease	2.68e-05	0.000115	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.58e-05	0.000111	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	2.58e-05	0.00011	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.56e-05	0.00011	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.56e-05	0.00011	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	2.56e-05	0.00011	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—POMC—coronary artery disease	2.56e-05	0.00011	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.51e-05	0.000108	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.5e-05	0.000107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	2.5e-05	0.000107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	2.49e-05	0.000107	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.47e-05	0.000106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	2.46e-05	0.000105	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.45e-05	0.000105	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	2.45e-05	0.000105	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.35e-05	0.000101	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.34e-05	0.0001	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.34e-05	0.0001	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	2.33e-05	0.0001	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.27e-05	9.72e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	2.26e-05	9.69e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.24e-05	9.59e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	2.23e-05	9.56e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—JAK2—coronary artery disease	2.17e-05	9.32e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	2.17e-05	9.29e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	2.13e-05	9.13e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.12e-05	9.1e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.98e-05	8.51e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.98e-05	8.48e-05	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.92e-05	8.22e-05	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.91e-05	8.19e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.9e-05	8.14e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.89e-05	8.11e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.89e-05	8.09e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.88e-05	8.06e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.85e-05	7.92e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.84e-05	7.9e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.79e-05	7.69e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.79e-05	7.67e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.74e-05	7.46e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.73e-05	7.44e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.61e-05	6.91e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.61e-05	6.89e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.48e-05	6.34e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	1.47e-05	6.32e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.45e-05	6.22e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	1.45e-05	6.2e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.26e-05	5.4e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.25e-05	5.38e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.11e-05	4.78e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.11e-05	4.76e-05	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKT1—coronary artery disease	1.03e-05	4.41e-05	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.02e-05	4.39e-05	CbGpPWpGaD
